Search

everythinglearnresearchcommunity

for

Search:↓

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Skin reactions from cancer treatments might predict how well the treatments work.

Genetic discoveries are leading to new treatments for alopecia areata.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Some drugs may help treat both COVID-19 and radiation injury.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Six genetic conditions are often linked to complete scalp hair loss in children.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Non-drug therapies show promise for hair regrowth but need more research.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

SIRT7 protein is crucial for starting hair growth in mice.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Thiopurines help treat IBD but require genetic testing to avoid side effects.